GLP-1 receptor agonists in primary care: readiness, equity, and the risk of a two-tiered obesity treatment landscape.
Saved in:
| Title: | GLP-1 receptor agonists in primary care: readiness, equity, and the risk of a two-tiered obesity treatment landscape. |
|---|---|
| Authors: | Ahmed MM; Faculty of Medicine and Health Sciences, SIMAD University, Mogadishu 252, Somalia., Nazari R; Faculty of Dentistry, Cheragh Medical University, Kabul, Afghanistan., Othman ZK; Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand., Musa SS; School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Okesanya OJ; Department of Medical Laboratory Science, Neuropsychiatric Hospital, Abeokuta, Nigeria., Adebayo UO; Department of Digital Health, Global Health Focus Africa, Kigali, Rwanda., Branda F; Unit of Medical Statistics and Molecular Epidemiology, Campus Bio-Medico University of Rome, Rome, Italy., Elmi AH; Department of Nursing, Faculty of Medicine and Health Sciences, Dr. Sumait Hospital, SIMAD University, Mogadishu, Somalia., Lucero Prisno DE 3rd; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK. |
| Source: | Therapeutic advances in endocrinology and metabolism [Ther Adv Endocrinol Metab] 2026 Jul 27; Vol. 17, pp. 20420188261472587. Date of Electronic Publication: 2026 Jul 27 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Sage Publication Country of Publication: United States NLM ID: 101532143 Publication Model: eCollection Cited Medium: Print ISSN: 2042-0188 (Print) Linking ISSN: 20420188 NLM ISO Abbreviation: Ther Adv Endocrinol Metab Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
